ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $415,427 | -93.2% | 1,115 | -93.5% | 0.01% | -92.9% |
| Q3 2022 | $6,085,000 | -40.9% | 17,236 | -36.6% | 0.08% | -46.5% |
| Q2 2022 | $10,299,000 | -38.3% | 27,184 | -48.7% | 0.16% | -41.3% |
| Q1 2022 | $16,705,000 | +23.9% | 52,979 | +18.3% | 0.27% | +8.0% |
| Q2 2021 | $13,479,000 | +648.4% | 44,769 | +584.5% | 0.25% | +527.5% |
| Q1 2021 | $1,801,000 | – | 6,540 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |